FDA Puts Kibosh On Perfectly Posh For Unapproved Drug Claims
This article was originally published in The Rose Sheet
Executive Summary
Perfectly Posh, which sells a colorful range of skin, hair and bath products online and through independent social sellers, draws an FDA warning letter for claims about acne, eczema and dandruff treatment, among others.
You may also be interested in...
Soap Maker Warned As FDA's Cosmetics Enforcement Activity Picks Up
FDA has issued three warning letters to cosmetic product marketers over the past month. The agency cites Soapwalla for violative claims on bar soaps, while Star Health & Beauty's purported cosmetics and dietary supplements are not only unapproved drugs, but also adulterated in some cases due to GMP violations.
FDA To Curtail Cosmetics Safety Work Under FY 2018 Budget Constraints
President Trump's budget proposal for fiscal 2018 calls for "targeted reductions to the Food Safety program, including reducing staff levels through attrition." In its justification to congressional appropriators, FDA says it will reduce funding for cosmetics safety work in order to focus on top priorities in the broad foods area.
FDA Targets DermaTox Maker In Year’s First Published Warnings To Cosmetics Firms
Healthy Habits reacts indignantly to FDA’s warning about testimonials for DermaTox products featured on its website, which the agency says identify the items as unapproved drugs. Aegeia Skin Care also receives a warning letter for structure/function and disease-treatment claims on its facial- and body-care products.